Tarec Christoffer El‐Galaly

Has grant

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Kræftens Bekæmpelses Juniorforskerpris

Open Date: 2017-04-01

Close Date: 2018-04-01

Grant: Close

Støtte til kræftforskningen i Nordjylland

Open Date: 2016-05-01

Close Date: 2018-04-01

Grant: Close

Outcome of CNS relapse in diffuse large B-cell lymphoma

Open Date: 2015-01-01

Close Date: 2015-01-01

Grant: Close

Individual prediction of drug resistance (2016-2017)

Open Date: 2015-01-01

Close Date:

Grant: Close

Predicting CNS relapse in diffuse large B-cell lymphoma

Open Date: 2014-01-01

Close Date: 2014-01-01

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Tove Wästerlid

SWEDEN

View details

Ingrid Glimelius

SWEDEN

View details

Torsten Holm Nielsen

Zealand University Hospital

DENMARK

View details

Francesco Passamonti

ITALY

View details

Inger Lise Gade

Aalborg University

DENMARK

View details

Martin B. Pedersen

Aarhus University

DENMARK

View details

Thomas Stauffer Larsen

Odense University Hospital

DENMARK

View details

Izabela Ewa Nielsen

Aalborg University

DENMARK

View details

Eliza Hawkes

Associate Professor

MONASH UNIVERSITY

AUSTRALIA

View details

Joel Joelsson

Karolinska Institutet

SWEDEN

View details

Lars Børty Nielsen

Aalborg University

DENMARK

View details

Cecilia Radkiewicz

Karolinska Institutet

SWEDEN

View details

Martin Hutchings

Professor

University of Copenhagen

DENMARK

View details

Richard Rosenquist

Karolinska Institutet

SWEDEN

View details

Henrik Frederiksen

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tarec Christoffer El‐Galaly

Research Interests

Contact this professor

Recent Grants

Articles (21)

The Prevalence of Diffuse Large B‐Cell Lymphoma Varies Substantially by Methods Applied: Results From a Population‐Based Study

Acute leukaemia: Patient factors associated with unplanned diagnostic pathways and the impact on survival – A nationwide register-based cohort study in Denmark

Lymphoma: factors associated with unplanned diagnostic pathways and survival –a nationwide Danish register-based cohort study

Classification of α-thalassemia data using machine learning models

Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma

Analysis of temporal survival trends: considerations and best practice

Prevalence and incidence of mastocytosis in adults: a Danish nationwide register study

MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial.

Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study

The use of metformin and risk of myeloproliferative neoplasms among patients with no registered markers of diabetes

Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy

Sex differences in lymphoma incidence and mortality by subtype: A population‐based study

Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study

The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study

Bone health and glucocorticoid‐containing lymphoma therapy — a review of risk factors and preventative measures

Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack?

A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment

Pre‐treatment total metabolic tumour volumes in lymphoma: Does quantity matter?

Routine imaging for disease surveillance in follicular lymphoma—To comfort the patients or their doctors?

Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system

Treatment intensity and survival trends among real-world elderly AML patients diagnosed in the period 2001–2016: a Danish nationwide cohort study

Collaborators (15)

Tove Wästerlid

Ingrid Glimelius

Torsten Holm Nielsen

Francesco Passamonti

Inger Lise Gade

Martin B. Pedersen

Thomas Stauffer Larsen

Izabela Ewa Nielsen

Eliza Hawkes

Joel Joelsson

Lars Børty Nielsen

Cecilia Radkiewicz

Martin Hutchings

Richard Rosenquist

Henrik Frederiksen

Make your next move.